Recurrence of Melanoma Following T Cell Treatment: Continued Antigen Expression in a Tumor That Evades T Cell Recruitment-Reference-Cited by-同舟云学术

Recurrence of Melanoma Following T Cell Treatment: Continued Antigen Expression in a Tumor That Evades T Cell Recruitment

Published:2015-02 Issue:2 Volume:23 Page:396-406
ISSN:1525-0016
Container-title:Molecular Therapy
language:en
Short-container-title:Molecular Therapy

Author:

Straetemans Trudy,Berrevoets Cor,Coccoris Miriam,Treffers-Westerlaken Elike,Wijers Rebecca,Cole David K,Dardalhon Valerie,Sewell Andrew K,Taylor Naomi,Verweij Jaap,Debets Reno

Publisher

Elsevier BV

Subject

Drug Discovery,Pharmacology,Genetics,Molecular Biology,Molecular Medicine

Reference51 articles.

1. Clinical responses in a phase II study using adoptive transfer of short-term cultured tumor infiltration lymphocytes in metastatic melanoma patients;Besser;Clin Cancer Res,2010

2. Adoptive cell transfer therapy following non-myeloablative but lymphodepleting chemotherapy for the treatment of patients with refractory metastatic melanoma;Dudley;J Clin Oncol,2005

3. TCR-Engineered T Cells Meet New Challenges to Treat Solid Tumors: Choice of Antigen, T Cell Fitness, and Sensitization of Tumor Milieu;Kunert;Front Immunol,2013

4. T cell receptor gene therapy: strategies for optimizing transgenic TCR pairing;Govers;Trends Mol Med,2010

5. Adoptive T cell therapy using antigen-specific CD8+ T cell clones for the treatment of patients with metastatic melanoma: in vivo persistence, migration, and antitumor effect of transferred T cells;Yee;Proc Natl Acad Sci USA,2002

Cited by 22 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Experimental and clinical evidence in favour of an effective immune stimulation in ER-positive, endocrine-dependent metastatic breast cancer;Frontiers in Immunology;2024-01-25

2. Nucleolar protein TAAP1/C22orf46confers pro-survival signaling in non-small cell lung cancer;Life Science Alliance;2024-01-16

3. Transient cell-in-cell formation underlies tumor relapse and resistance to immunotherapy;eLife;2022-09-20

4. Vasculogenic mimicry structures in melanoma support the recruitment of monocytes;OncoImmunology;2022-03-09

5. Anti–PD-1 Efficacy in Patients with Metastatic Urothelial Cancer Associates with Intratumoral Juxtaposition of T Helper-Type 1 and CD8+ T cells;Clinical Cancer Research;2021-10-06